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Abstract
Brucellosis is one of the most widespread bacterial zoonoses worldwide. Here, our aim was
to identify the effector mechanisms controlling the early stages of intranasal infection with
Brucella in C57BL/6 mice. During the first 48 hours of infection, alveolar macrophages
(AMs) are the main cells infected in the lungs. Using RNA sequencing, we identified the aco-
nitate decarboxylase 1 gene (Acod1; also known as Immune responsive gene 1), as one of
the genes most upregulated in murine AMs in response to B. melitensis infection at 24 hours
post-infection. Upregulation of Acod1 was confirmed by RT-qPCR in lungs infected with B.
melitensis and B. abortus. We observed that Acod1-/- C57BL/6 mice display a higher bacte-
rial load in their lungs than wild-type (wt) mice following B. melitensis or B. abortus infection,
demonstrating that Acod1 participates in the control of pulmonary Brucella infection. The
ACOD1 enzyme is mostly produced in mitochondria of macrophages, and converts cis-aco-
nitate, a metabolite in the Krebs cycle, into itaconate. Dimethyl itaconate (DMI), a chemi-
cally-modified membrane permeable form of itaconate, has a dose-dependent inhibitory
effect on Brucella growth in vitro. Interestingly, structural analysis suggests the binding of
itaconate into the binding site of B. abortus isocitrate lyase. DMI does not inhibit multiplica-
tion of the isocitrate lyase deletion mutant ΔaceA B. abortus in vitro. Finally, we observed
that, unlike the wt strain, the ΔaceA B. abortus strain multiplies similarly in wt and Acod1-/-
C57BL/6 mice. These data suggest that bacterial isocitrate lyase might be a target of itaco-
nate in AMs.
PLOS PATHOGENS
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Author summary
Brucellosis is one of the most widespread bacterial zoonoses worldwide. Here, our aim
was to identify the effector mechanisms controlling the early stages of intranasal infection
with Brucella in mice. During the first 48 hours of infection, alveolar macrophages (AMs)
are the main cells infected in the lungs. Using RNA sequencing, a hypothesis-free
approach, we identified the aconitate decarboxylase 1 gene (Acod1) as one of the genes
most upregulated in murine AMs in response to B. melitensis infection. We observed that
mice deficient for Acod1 display a higher bacterial load in their lungs than wild-type (wt)
mice following B. melitensis or B. abortus infection, demonstrating that Acod1 participates
in the control of pulmonary Brucella infection. We observed that, unlike the wt strain of
B. abortus, the isocitrate lyase (ICL) deficient B. abortus strain multiplies similarly in wt
and Acod1 deficient mice, suggesting that bacterial ICL might be a target of Acod1 in
AMs. As the mouse ACOD1 enzyme is*80% identical in its amino acid sequence to the
human ACOD1, the development of pharmacological agents that enhance ACOD1 func-
tion might help to control early stages of pulmonary Brucella infection.
Introduction
Brucella spp. are facultative intracellular Gram-negative coccobacilli that infect mammals and
cause brucellosis (reviewed in [1–4]). Human brucellosis is a zoonotic infection that is mainly
transmitted through ingestion of food contaminated with Brucella. Aerosol contamination is
also common following Brucella-induced abortions in farm animals or in butcher shops han-
dling infected meats. Without prolonged antibiotics treatment, brucellosis causes a severe and
debilitating chronic disease [1, 5].
The mouse is the experimental animal model most commonly used to study Brucella infec-
tion [6]. Following intranasal infection, B. melitensis multiplies in the lungs for several days
before spreading to draining lymph nodes and then to the spleen where it persists for months
[7]. Mice chronically infected with B. melitensis develop a protective memory response able to
efficiently control a secondary Brucella infection [8]. However, this response is not able to
eliminate bacteria that settled in CD11c+ splenic reservoir cells during primary infection [9],
suggesting that splenic reservoir cells constitute a niche that hides Brucella from the Interferon
(IFN)-γ-mediated protective immune response [10, 11]. Thus, in order to develop new thera-
peutic strategies against brucellosis, it would be very useful to identify the early mechanisms
acting against Brucella in the lungs before it establishes its niche in the spleen.
Over the course of evolution, Brucella has acquired specific stealth strategies that allow it to
reduce or interfere with its recognition by the immune system and neutralize immune effector
mechanisms (reviewed in [3, 12]). Consequently, the inflammatory response against Brucella
is particularly weak and difficult to detect. We showed previously that TCR-δ, TAP1, and IL-
17RA deficiencies affect the early control of B. melitensis in the lungs (5 days post-infection)
[8]. At high doses of infection, IL-1R and inflammasomes appear to be involved in early
immune protective mechanisms against respiratory B. abortus infection (7 days post-infection)
[13]. However, the precise effector immune mechanisms involved in early control of Brucella
remain largely unknown.
Alveolar macrophages (AMs) are well known to act as first-line pulmonary immune senti-
nels and constitute the dominant immune cells in lungs at steady state [14]. In the first days of
intranasal infection, CD11c+ F4/80+ AMs constitute the main pulmonary cells infected with
Brucella [7, 15]. Their elimination increases the spread of B. abortus to the draining lymph
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nodes [15], suggesting that they are able to partially control Brucella multiplication. AMs per-
form a critical homeostatic role by clearing inhaled material from the airways and recycling
pulmonary surfactant [14]. Via these steady-state functions, AMs express unique transcrip-
tional and epigenetic profiles that are highly distinct from those of other tissue-resident macro-
phages [16]. It is therefore not surprising that Brucella was shown to induce weak IL-1β, IL-6,
and TNF-α production in lung alveolar macrophages in vitro compared with peritoneal mac-
rophages [17].
In the present study, to identify the mechanisms involved in the control of Brucella by
AMs, we have chosen to use an unbiased approach involving RNA sequencing (RNAseq) on
whole lung and purified AM samples from mice infected by the intranasal route with B. meli-
tensis. We observed that the Acod1/Irg1 gene, which codes for cis-aconitate decarboxylase 1
[18], is among the genes most overexpressed in response to infection and we demonstrate that
Acod1 participates in the direct control of B. melitensis and B. abortus multiplication in AMs.
Results
Acod1 is among the genes most upregulated in alveolar macrophages from
B. melitensis infected mice
In order to identify the immune effector mechanisms controlling the early multiplication of
Brucella melitensis in the lungs, we compared gene expression in the lungs of B. melitensis-
infected and PBS-treated wild-type (wt) C57BL/6 mice. Mice were infected with 107 CFU of B.
melitensis and sacrificed 24 hours later. Lungs were harvested and analyzed by RNA sequencing.
The results of this analysis are presented in S1 Data. A volcano plot representation of these data
shows that only a very low number of genes is significantly downregulated or upregulated dur-
ing infection (Fig 1A). The 5 downregulated genes are immunoglobulin heavy variable 5–6
(Ighv5-6), Elongation of very long chain fatty acids protein 6 (Elovl6), Immunoglobulin heavy
variable 1–81 (Ighv1-81), Acetyl-CoA carboxylase 1 (Acaca), mitochondrially encoded tRNA
asparagine (mt-Tn). The 5 upregulated genes are Lipocalin-2 (Lcn2), that participates in the
innate immune response against bacteria by sequestering iron [19], Krüppel-like Factor 2
(Klf2), Iroquois homeobox 1 (Irx1) and CCAAT enhancer binding protein delta (Cebpd) that
are transcription factor genes and Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (Itih4).
We hypothesize that the early immune response against Brucella is not systemic in the lung
and should be investigated at the cellular level, in the first cells infected with Brucella. Follow-
ing intranasal infection, alveolar macrophages (AMs) constitute the main pulmonary cells
infected with B. melitensis [7] and B. abortus [15] between 2 and 24 hours. In order to confirm
this in our experimental model, we intranasally infected wt C57BL/6 mice with 107 CFU of
mCherry-B. melitensis stained with the fluorescent tracer eFluor670 which is used to visualize
the cells infected with B. melitensis by flow cytometry [7]. We confirm that the main cells
infected at 24 hours post-infection express the CD11c and Siglec-F markers (89.9% of all cells
infected) and are therefore indeed AMs (S1A Fig). Then, in biosafety level 3 conditions, we
purified the low-density lung cells expressing the CD11c marker in mice infected for 24 hours
with 107 CFU of eFluor670-stained mCherry-B. melitensis. This cell fraction was highly
enriched in infected cells of the AM type and contained 73% CD11c+ eFluor+ cells (S1B Fig).
We compared the gene expression in an enriched AM fraction purified from the lungs of B.
melitensis-infected and PBS-treated wt C57BL/6 mice. The results of this analysis are presented
in S2 Data. A volcano plot representation of these data shows that 466 genes (R1 genes) were
significantly upregulated in the infected mice (Fig 1B). We used the Metascape platform to
perform a pathway enrichment analysis of these genes. The first signature identified was the
response to interferon-beta (Fig 1C). The genes associated with this signature (R2 genes) were
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Fig 1. Identification of the most upregulated genes in lungs and alveolar macrophages from B. melitensis-infected
mice. Wild-type C57BL/6 mice intranasally infected with 107 CFU of wild-type B. melitensis 16M (n = 3), or receiving
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represented on a heatmap to see the expression of each gene in this pathway (Fig 2). Among
them, some genes have been described to play an effector role in the innate immune response
against intracellular pathogens. IFN-gamma-inducible GTP-binding protein (Igtp) participates
in the disruption of Toxoplasma gondii vacuoles [20]. Guanylate-binding protein (Gbp)3 and
Gbp6 regulate cell-autonomous immunity in macrophages by coordinating a potent oxidative
and vesicular trafficking program to protect the host from intracellular bacteria [21]. The
implication of GBP proteins in the Stimulator of Interferon Genes (STING)-dependent type I
interferon response against B. abortus has already been described [22]. One very interesting
candidate is the Acod1/Irg1 gene which has been described to act as a direct effector against
intracellular bacteria as well as a regulator of the inflammatory response (reviewed in [23]).
Acod1 deficiency induces a lack of Brucella control in the lungs
As a first attempt to establish a role of ACOD1 in the control of intracellular Brucella multipli-
cation, we infected in vitro bone marrow derived macrophages (BMDMs) from wild-type or
Acod1-/- C57BL/6 mice with B. melitensis or B. abortus. We observed that the multiplication of
both Brucella species is not significantly affected by Acod1 deficiency in BMDMs (Fig 3). Oth-
ers [24] have shown that during M. tuberculosis infection Acod1 deficiency affects the control
of infection in vivo but not in vitro. Thus, to formally determine whether or not ACOD1 par-
ticipates in the control of Brucella infection, we compared the CFU count of bacteria in the
lungs and spleen of wt and Acod1-/- C57BL/6 mice intranasally infected with 107 CFU of wt B.
melitensis or B. abortus (Fig 4A). We observed that Acod1-/- mice infected with B. melitensis
only displayed significantly enhanced CFU at 9 days post-infection in the lungs, compared to
wt mice. In contrast, CFU counts were significantly enhanced at 2-, 5- and 9-days post-infec-
tion in Acod1-/- mice infected with B. abortus. This difference may be the consequence of the
lower induction of Acod1 in response to infection with B. melitensis (Fig 4B). In agreement,
Acod1 deficiency had only a minimal impact on the course of B. melitensis and B. abortus in
the spleen (Figs 4A and S2) where no Acod1 expression was detected (Fig 4B).
Finally, we also compared the CFU count of bacteria in the spleen of wt and Acod1-/-
C57BL/6 mice intraperitoneally infected with 107 CFU of wt B. abortus (S3 Fig). We observed
that Acod1 deficiency does not affect the control of B. abortus in spleen, which suggests that
Acod1 would only play a role in specific organs such as lungs.
Enhanced susceptibility of Brucella-infected Acod1-/- mice is not associated
with higher inflammation in the lungs
Acod1 deficiency has been associated with a lack of inflammatory control in several models of
bacterial [24] and viral [25] infection in mice. For example, Acod1-/- but not wt C57BL/6 mice
the same volume of PBS (naïve group) (n = 3) were sacrificed at 24 hours post-infection. Lungs were harvested and
alveolar macrophages isolated as described in Materials and Methods. Then, RNA was extracted and sequenced with
the Illumina system and Deseq2 analysis as described in the Materials and Methods. (A) Volcano plot of RNA-seq data
from naïve versus infected lungs shows the adjusted p-value (false discovery rate, FDR -log10) versus fold change, FC
(log2). The 5 upregulated genes are Lipocalin-2 (Lcn2), Krüppel-like Factor 2 (Klf2), Iroquois homeobox 1 (Irx1),
CCAAT enhancer binding protein delta (Cebpd), Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (Itih4). The 5
downregulated genes are immunoglobulin heavy variable 5–6 (Ighv5-6), Elongation of very long chain fatty acids
protein 6 (Elovl6), Immunoglobulin heavy variable 1–81 (Ighv1-81), Acetyl-CoA carboxylase 1 (Acaca),
mitochondrially encoded tRNA asparagine (mt-Tn). (B) Volcano plot of RNA-seq data from naïve versus infected
alveolar macrophages shows the adjusted p-value (false discovery rate, FDR -log10) versus fold change, FC (log2). The
466 genes with an FDR< 0.05 and FC> 1.5 are shown in the R1 green square. Acod1 is the 178th most upregulated
gene. (C) The R1 genes from alveolar macrophages were copy-pasted in Metascape (https://metascape.org) to perform
a pathway enrichment analysis. Data are representative of two independent experiments.
https://doi.org/10.1371/journal.ppat.1009887.g001
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intranasally infected with M. tuberculosis succumbed rapidly, and mortality was associated
with increased infection, neutrophilia and production of inflammatory cytokines [24]. Deple-
tion of neutrophils enhances survival of M. tuberculosis-infected Acod1−/− mice.
In order to determine whether Acod1 tempered Brucella-induced inflammation in our
experimental model or not, we analyzed the cellular recruitment induced by B. abortus in the
lungs of infected mice. Wt and Acod1-/- C57BL/6 mice were infected with 107 CFU of B. abor-
tus and sacrificed 9 days post-infection. The lungs were removed and analyzed by flow cytome-
try and fluorescence microscopy. The cytometric analysis shows that B. abortus infection
induced a significant increase in the number of monocytes, CD4+T cells and γδT cells and a
significant decrease of alveolar macrophages and eosinophils number (Figs 5 and S4 for gating
strategy). However, these changes in cellular composition of the lungs did not differ signifi-
cantly between wt and Acod1-/- mice. Similarly, histological analysis showed no clear differ-
ences between B. abortus infected lungs of wild-type and Acod1-/- mice in terms of
recruitment of neutrophils and we did not observe clusters of neutrophils (GR1+ cells) around
Fig 2. Response to interferon-beta genes” are upregulated at 24 hours post B. melitensis infection in mice. “ The
response to interferon-beta genes from the first pathway resulting from the Metascape analysis (see Fig 1C) were
represented on a heatmap to see the expression of each gene in the pathway. The color scale indicates the Z score.
RNAseq was performed at least two times and each sample was generated from a pool of at least 3 mice.
https://doi.org/10.1371/journal.ppat.1009887.g002
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cells infected with B. abortus in the lungs (Fig 6). Finally, measurement of the expression of
the proinflammatory cytokines TNF-α, IL-1β and IL-6 in these mice by RT-qPCR showed that
these cytokines were indeed induced by B. abortus infection but were not significantly more
expressed in the Acod1-/- mice than in the wt mice (Fig 7). On the whole, our data show that
Acod1 deficiency did not lead to a detectable increase of inflammation in mice infected with B.
abortus.
Fig 3. Acod1 is dispensable for Bone marrow derived macrophages control of Brucella infection. Bone marrow
derived macrophages from wild type and Acod1-/- C57BL/6 mice were infected with B. melitensis or B. abortus at an
MOI of 50:1, as indicated in Materials and Methods. At various timepoints after infection (5h, 24h and 48h),
intracellular CFU levels were measured. Error bars depict S.D. of the mean. Data are representative of 4 independent
experiments. ns = non-significant.
https://doi.org/10.1371/journal.ppat.1009887.g003
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In neutral pH conditions, dimethyl itaconate and 4-octyl itaconate, but not
itaconate, inhibit Brucella growth in culture
The Acod1 gene codes for a cis-aconitate decarboxylase that converts cis-aconitate into itaco-
nate [18]. The itaconate concentration reached 5 mM in mouse Bone Marrow-Derived Macro-
phages (BMDMs) after LPS stimulation [26]. It has been reported that itaconate could directly
inhibit the in vitro multiplication of many bacteria such as Salmonella enterica, Mycobacterium
tuberculosis [18], Legionella pneumophila, Staphylococcus aureus and Acinetobacter baumannii
[27]. As expected, we found that itaconate completely inhibited the in vitro growth of B. meli-
tensis and B. abortus in rich acidic medium (2YT, pH ~3.5) at concentration (8–12 mM) close
to those measured in stimulated BMDMs (Fig 8A). Surprisingly, at neutral pH in 2YT, itaco-
nate did not seem to have any significant effect on Brucella multiplication in vitro, regardless
of the species (Fig 8B). This may have been due to the inability of itaconate to cross the bacte-
rial membrane because of its charged nature. In vivo, after phagocytosis, Brucella is thought to
be at acidic pH in the phagolysosome of the host cell, thus increasing the possibility of
increased membrane permeability. Therefore, itaconate might be able to enter Brucella in
physiological conditions in vivo and exert its potentially inhibitory effect. To validate this
hypothesis, we tested the impact of different concentrations of dimethyl itaconate (DMI) [28],
a membrane-permeable non-ionic form of itaconate, on the multiplication of B. melitensis and
B. abortus in vitro at neutral pH. We observed that DMI inhibits the growth of both Brucella
species in a dose-dependent manner in rich medium (2YT) (Fig 9A), suggesting that itaconate
is able to specifically affect Brucella when it can cross its membrane. Similar, results were
obtained with 4-octyl itaconate [26], another membrane-permeable non-ionic form of itaco-
nate (S5 Fig).
B. abortus bacteria incubated for 24 hours in the presence of 10 mM DMI in 2YT, washed
and then cultured again in the absence of DMI showed 100 times less CFU than control bacte-
ria not treated with DMI (S6 Fig), which demonstrates that DMI is bactericidal for B. abortus.
Inhibition of Brucella growth in culture by dimethyl itaconate is isocitrate
lyase-dependent
Itaconate has been described to act via the bacterial enzyme isocitrate lyase (ICL) [18] which is
part of the glyoxylate shunt that is exclusively found in prokaryotes, lower eukaryotes, and
plants. This alternative shunt is activated in response to nutrient deprivation, a condition
encountered by bacteria in phagolysosomes [29].
Starting from the crystal structure of isocitrate lyase from B. abortus in complex with malo-
nate (Protein Data Bank (PDB) entry 3OQ8) docking of itaconate has been performed and
suggests a good binding of this compound in the active site of the protein (Fig 10A). The
ligand is stabilized in the enzyme by salt bridges involving the two carboxylate groups of itaco-
nate and residues Lys183, Arg222, and His187 (Fig 10B). A network of Hydrogen bonds fur-
ther stabilizes the ligand inside the enzyme (Fig 10C). Interestingly, this docking pose places
Fig 4. Acod1 gene expression is correlated to Brucella control in the lungs. (A) Wild-type and Acod1-/- C57BL/6 mice were intranasally
infected with 107 CFU of wild-type B. melitensis 16M or B. abortus 2308, as indicated. At 2-, 5-, 9- and 28-days post-infection, lungs and
spleen were harvested and CFU were counted. Each point represents one mouse. n = number of mice used. Grey bar represents the mean.
Significant differences between the indicated groups are marked with asterisks: �p< 0.05, ��p< 0.01. ns = non-significant. Data are
representative of at least 3 independent experiments. (B) Wild-type C57BL/6 mice were intranasally infected with 108 CFU of wild-type B.
melitensis 16M or B. abortus 2308, as indicated. At 2-, 5-, 9- and 28-days post-infection, lungs and spleen were harvested and RNA was
extracted. After reverse-transcription into cDNA, qRT-PCR was performed with Acod1 primers. At least 6 mice were pooled for each
condition. The data are representative of 3 independent experiments. The mean fold change number is indicated at the top of the
histogram bar.
https://doi.org/10.1371/journal.ppat.1009887.g004
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the carbon atom of the reactive double bond of itaconate in close proximity with the lateral
chain of Cys185, suggesting a possible nucleophilic attack by the thiol of this residue leading to
a covalent adduct between isocitrate lyase and itaconate. This docking pose has been experi-
mentally confirmed by crystallography (PDB entry 7RBX) that unambiguously shows a cova-
lent adduct between itaconate and Cys185 in B. abortus isocitrate lyase (Fig 10D).
Fig 5. Enhanced susceptibility of B. abortus infected Acod1-/- mice is not associated to different cell recruitment in
the lungs. Wild-type and Acod1-/- C57BL/6 mice were intranasally infected with 107 CFU of wild-type mCherry
expressing B. abortus 2308. At 9 days post-infection, mice were sacrificed and lungs were harvested. Lung cells were
isolated and then analyzed by flow cytometry as described in S6 Fig. Uninfected mice served as controls. Significant
differences between the indicated groups are marked with asterisks: �p< 0.05, ��p< 0.01, ���p< 0.001. ns = non-
significant. The cells were counted out of the total number of cells by organ. Data represent the number of different cell
populations per lung from individual mice. 3 and 6 mice were used for the control or infected condition, respectively.
These data are representative of 2 independent experiments.
https://doi.org/10.1371/journal.ppat.1009887.g005
Fig 6. Enhanced susceptibility of B. abortus infected Acod1-/- mice is not associated to higher cell recruitment in the lungs. Wild-type and Acod1-/- C57BL/6 mice
were intranasally infected with 107 CFU of wild-type mCherry expressing B. abortus 2308. At 9 days post-infection, mice were sacrificed and lungs were harvested.
Lungs were fixed and embedded. 5 μm-thick slides of were made with a cryostat. Slides were stained and analyzed by fluorescent microscopy for the expression of DAPI,
phalloidin, mCherry and neutrophil (GR1) marker. The yellow triangles indicate the presence of B. abortus expressing the mCherry fluorescent tracer. These images are
representative of at least 2 independent experiments on at least 3 mice per group.
https://doi.org/10.1371/journal.ppat.1009887.g006
PLOS PATHOGENS Role of Acod1 in Brucella infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009887 September 15, 2021 11 / 27
We compared the effect of DMI on the growth of a wt strain and an ICL-deficient strain
(ΔaceA) of B abortus in a defined minimal medium for Brucella, the Plommet-Erythritol
medium [30]. We observed that the growth of the ΔaceA strain was much less affected by DMI
than the wt strain (Fig 9B). Complementation of the ΔaceA mutant with a plasmid encoding
ICL renders it sensitive to DMI, which demonstrates that itaconate acts via ICL to inhibit the
multiplication of B. abortus under our experimental conditions. In contrast, dimethyl fumarate
(DMF), which has been described to inhibit the growth of E. coli [31], reduces the growth of
wt and ΔaceA B. abortus similarly (Fig 9C), suggesting that DMI is specifically responsible for
the ICL-dependent inhibition of B. abortus growth.
DMI treatment induces significant morphological changes in Brucella. Transmission elec-
tron microscopy (TEM) analysis shows that wt B. abortus treated for 24 hours with 1 mM
DMI present significant thickening of the envelope (S7 Fig). However, these alterations are
also observed with DMI-treated ΔaceA B. abortus, demonstrating that these envelope defects
do not correlate with the growth inhibition effect of DMI.
Acod1 deficiency does not affect the growth of ΔaceA B. abortus in vivo
Finally, to determine whether Acod1-dependent control of Brucella infection in vivo is acting
via bacterial ICL, wt and Acod1-/- C57BL/6 mice were intranasally infected with 107 CFU of wt
or ΔaceA B. abortus and sacrificed 9 days post-infection. In striking contrast with the wt strain
of B. abortus, CFU analysis of lungs from infected mice showed that growth of the ΔaceA strain
was not affected by Acod1 deficiency (Fig 11), demonstrating that ACOD1 control of B. abor-
tus in the lungs is indeed dependent on the expression of ICL by Brucella. In addition, the fact
Fig 7. Enhanced susceptibility of B. abortus infected Acod1-/- mice is not associated with higher pro-inflammatory
cytokine expression in the lungs. Wild-type (red) and Acod1-/- (blue) C57BL/6 mice were intranasally infected with
107 CFU of wild-type mCherry expressing B. abortus 2308. At 9 days post infection, mice were sacrificed, lungs were
collected, RNA was extracted and qRT-PCR was performed. TNF-α, IL-1β, and IL-6 expression levels were analyzed.
Tbp gene was used as negative control, and RNA from naïve mice was used as the standard condition. Data show the
fold increase of RNA expression for the indicated cytokine from infected mice compared to control mice. At least 6
mice were pooled for each condition. The data are representative of 3 independent experiments. ns = non-significant.
https://doi.org/10.1371/journal.ppat.1009887.g007
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that the CFU in Acod1-/- mice infected with wt and ΔaceA B. abortus were comparable is con-
sistent with the hypothesis that ICL is the main target of ACOD1.
Discussion
Mucosal surfaces are portals of entry for the vast majority of pathogens. In the case of brucello-
sis, natural infections take place mainly via the intestinal [32] and respiratory tracts [33].
Despite this, little is known about the immune mechanisms controlling Brucella at the mucosal
level. We have shown previously that the early multiplication of B. melitensis in the lungs of
Fig 8. At neutral pH, itaconate does not inhibit Brucella growth in vitro. Comparison of the impact of different concentrations of itaconate on the growth of wild-
type B. melitensis (left-hand panel) or B. abortus (right-hand panel) in rich medium (2YT). A. acidic itaconate (pH’ 3.6). B. neutralized itaconate solution (pH = 7.0).
The bacteria were grown for 72 hours at 37˚C and the OD was measured every 30 min in a Bioscreen system. The standard deviation was obtained from three
independent experiments.
https://doi.org/10.1371/journal.ppat.1009887.g008
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infected mice is controlled by the immune system. The comparison of mice genetically defi-
cient for key elements of the innate and adaptive immune response demonstrated that γδ T
lymphocytes, CD8 T lymphocytes as well as pathways dependent on the IL-17RA receptor
were involved [8]. However, the precise mechanisms directly controlling the proliferation of
Brucella in the lungs remain largely unknown. In order to identify them, we used an unbiased
approach that involved performing RNA sequencing of the whole lungs as well as the main
cells infected with Brucella, the alveolar macrophages.
Intranasal B. melitensis infection does not appear to induce any detectable systemic
response in the lungs at 24 hours post-infection, even at a dose of 107 CFU. RNA sequencing
analysis shows that only 5 genes display a significant increase in expression in the lungs from
infected wild type C57BL/6 mice. This contrasts sharply with the increase in the expression of
1526 genes observed in the lungs of wild type C57BL/6 mice after intranasal infection with 106
CFU of Legionella pneumophilia [27], but fits well with the stealth pathogen profile of Brucella
[3, 34]. However, analysis of the RNA profile of purified alveolar macrophages allowed us to
identify 466 genes whose expression was significantly increased compared to uninfected con-
trols, which shows that Brucella induces an immune response within infected cells. A cluster-
ing analysis carried out using Metascape led us to select several genes involved in the anti-
bacterial immune responses induced by type 1 interferon, such as Igtp, Gbp3, Gbp6 and Acod1.
Among these, Acod1 has been described to play dual roles in immunity and diseases (for a
review see [23]). We therefore chose to explore its role in the pulmonary immune response
against Brucella.
The Acod1 gene was originally identified in 1995 as a 2.3-kb cDNA from a library synthe-
sized from mRNA isolated from a murine macrophage cell line after LPS stimulation [35]. It is
markedly upregulated in response to pathogen-associated molecular patterns, such as LPS and
CpG and inflammatory cytokines, such as type I interferon and tumor necrosis factor. The
ACOD1 enzyme catalyzes itaconate metabolite production by cis-aconitate decarboxylation
and is mainly found in mitochondria of myeloid cells.
Itaconate is well described to downregulate pro-inflammatory cytokine and reactive oxygen
species production by multiple mechanisms [23]. Acod1 expression has been reported to tem-
per inflammation and prevent immune-related pathology during Mycobacterium tuberculosis
[24] and Respiratory Syncytial Virus [25] infections in mice. In striking contrast, in our Bru-
cella infection model, we showed that the absence of Acod1 does not significantly increase
proinflammatory cytokine production or cellular recruitment in the lungs of infected mice,
despite a significant increase in the bacterial load in the lungs. Again, this must be the conse-
quence of the stealth pathogen profile of Brucella.
Itaconate is also known for its ability to directly inhibit the multiplication of several bacteria
in vitro [18] and in vivo [27]. We have shown that two membrane-permeable forms of itaco-
nate, DMI and 4OI, fully inhibit Brucella multiplication in vitro. However, in mice, Acod1 defi-
ciency has only a moderate effect on the multiplication of Brucella. This can be explained by
the existence of multiple effector mechanisms controlling Brucella in vivo. For example, we
[36, 37] and others [38] have shown that a deficiency in inducible NO synthase (iNOS)
increases susceptibility to Brucella infection in mice. In addition, GBP proteins, whose
Fig 9. The multiplication of Brucella in vitro is inhibited by dimethyl itaconate via an isocitrate lyase-dependent mechanism. (A)
Comparison of the impact of different concentrations of dimethyl itaconate (DMI) on the growth of wild-type B. melitensis (left panel)
or B. abortus (right panel) in rich medium (2YT). (B) Comparison of the impact of 1 mM of DMI on the growth of wild-type, ΔaceA
and ΔaceA-complemented B. abortus in poor medium (Plommet-Erythritol). (C) Dimethyl fumarate (DMF) was used as control, in the
same conditions as (B). The bacteria were grown for 72 hours at 37˚C. The OD was measured every 30 min in a Bioscreen system. Data
points represent means and standard deviations of three independent experiments.
https://doi.org/10.1371/journal.ppat.1009887.g009
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Fig 10. Docking and crystallography supports binding of itaconate into the binding site of isocitrate lyase. (A)
Docking pose of itaconate (magenta) into the crystal structure of isocitrate lyase from Brucella abortus (PDB entry
3OQ8) suggests a good binding of this compound in the active site of the protein. (B) The ligand in stabilized in the
enzyme by salt bridges involving the two carboxylate groups of itaconate and residues Lys183, Arg222, and His187. A
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expression is also found to be increased in Brucella-infected alveolar macrophages, have been
described as participating in the control of Brucella in vitro and in vivo [22]. This could explain
that the deficiency of a single specific effector mechanism cannot lead to the collapse of the
entire protective response against Brucella. Surprisingly, although B. melitensis and B. abortus
display the same sensitivity to DMI and 4OI in vitro, Acod1 deficiency increases susceptibility
to B. abortus much more than to B. melitensis in lungs. This difference can be correlated to the
earlier and stronger induction of Acod1 expression in the lungs by B. abortus than by B. meli-
tensis following intranasal infection. This could be explained by the slightly higher CFU level
of B. abortus compared to B. melitensis in the lungs of wt mice. Another non-exclusive
network of Hydrogen bonds further stabilizes the ligand inside the enzyme. In this geometry, Cys185 is well positioned
to react with the reactive double bond of itaconate. (C) Docking suggests that a covalent adduct (magenta) can be
formed by reaction of the lateral thiol group of Cys185 (yellow sulfur atom) and the carbon atom of the reactive double
bond of itaconate. (D) The experimental crystal structure (blue) of the covalent complex of itaconate with B. abortus
isocitrate lyase (PDB entry 7RBX) confirms the docking pose (green).
https://doi.org/10.1371/journal.ppat.1009887.g010
Fig 11. Acod1 deficiency does not affect the growth of ΔaceA B. abortus in vivo. Wild-type and Acod1-/- C57BL/6
mice were intranasally infected with 107 CFU of wild-type or ΔaceA mCherry expressing B. abortus 2308, as indicated.
At 9 days post infection, mice were sacrificed, lungs were harvested and CFU were counted. Each point represents one
mouse, n = number of mice used for each condition. Grey bar represents the mean. Significant differences between the
indicated groups are marked with asterisks: ��p< 0.01. ns = non-significant. The data are representative of at least 3
independent experiments.
https://doi.org/10.1371/journal.ppat.1009887.g011
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possibility would be that genes involved in itaconate degradation are differentially regulated
between B. abortus and B. melitensis. Indeed, homologs of previously identified genes involved
in itaconate degradation in Yersinia pestis [ref PMID: 24657929], namely ripA (ict), ripB (ich)
and ripC (ccl), have homologs in B. abortus and B. melitensis (BAB1_1077/BMEI0928,
BAB1_1554/BMEI0478 and BAB2_0355/BMEII0413 respectively). In this scenario, B. meliten-
sis would more efficiently degrade itaconate than B. abortus in this model of infection.
During the submission of our article, a study by Lacey et al. [39] showing that Acod1 defi-
ciency led to a slightly but significant increase CFU count of B. melitensis in the lung but not
the spleen from intranasally infected mice has been published. This result fully confirms our
observations in the mouse model. The authors also report that Acod1 deficiency does not affect
the multiplication of B. melitensis in BMDMs, which confirms that the in vitro infection of
BMDM cannot be used as a predictive model for the infection of alveolar macrophages in vivo.
Itaconate is known to inhibit bacterial multiplication via isocitrate lyase (ICL), the key
enzyme of the glyoxylate shunt, a two-step metabolic pathway that acts as an alternative shunt
to the tricarboxylic acid cycle and is essential for bacterial growth under specific conditions. In
Mycobacterium tuberculosis, ICL also exhibits additional methyl-ICL activity that is required
for the detoxification of propionyl-CoA through the 2-methylcitrate cycle [18]. No attenuation
of the ICL-deficient B. abortus strain, ΔaceA, was reported in BALB/c mice [40]. We showed
that ΔaceA B. abortus is more resistant to itaconate inhibition in vitro than the wt bacterial
strain and displays similar multiplication in wt and Acod1-/- mice. On the whole, our results
support a model in which the ACOD1 enzyme, via the production of itaconate, restricts Bru-
cella replication in murine alveolar macrophages through a bacterial ICL-dependent mecha-
nism. This hypothesis is supported, in part, by docking studies that place the carbon atom of
the reactive double bond of itaconate in close proximity with the lateral chain of Cys185 in
B. abortus isocitrate lyase, potentially leading to a nucleophilic attack by the thiol and forma-
tion of a covalent adduct between isocitrate lyase and itaconate. This docking pose has been
experimentally confirmed by crystallography (PDB entry 7RBX) that unambiguously shows a
covalent adduct between itaconate and Cys185 in Brucella abortus isocitrate lyase. However,
aceA deficiency does not prevent or reduce Brucella multiplication in the lungs, demonstrating
that ICL is not essential to Brucella multiplication in this condition. This suggests that
Acod1-mediated ICL-dependent inhibition of Brucella multiplication in our murine infection
model is not explained by a simple blockage of the glyoxylate shunt or by the toxic accumula-
tion of propionyl-CoA. The precise mechanism of Brucella growth inhibition by itaconate
therefore remains to be elucidated. It is interesting to remark that DMI also induced massive
disorganization of the bacterial envelope, independently of ICL. One possible mechanism for
this effect could be the inhibition of several L,D-transpeptidases, which are enzymes that cross-
link the peptide stems of peptidoglycan. These enzymes have a cysteine in their active site and
itaconate is known to alkylate this residue.
Our results demonstrate that Acod1 plays very different roles depending on the bacterial
species. Its ability to regulate inflammation does not seem to be exercised against stealthy bac-
teria such as Brucella, although it is essential for the control of neutrophil-mediated immune-
related pathology during M. tuberculosis infection [24]. Itaconate is able to inhibit bacterial
multiplication through a variety of pathways, which might be reflective of metabolic differ-
ences between bacterial species.
In summary, our study provides the first evidence of a role of the Acod1 cis-aconitate decar-
boxylase enzyme producing itaconate in the pulmonary control of Brucella infection in a
mouse model. We also demonstrate that this control is exerted at the cellular level, in alveolar
macrophages, and acts via the bacterial enzyme isocitrate lyase. As the mouse ACOD1 enzyme
is*80% identical in its amino acid sequence to the human ACOD1, with all five predicted
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cis-aconitate decarboxylase domains fully conserved [18], the development of pharmacological
agents that enhance ACOD1 function or promote itaconate production might help to control
early stages of pulmonary Brucella infection.
Materials and methods
Ethics statement
The procedures used in this study and the handling of the mice complied with current Euro-
pean legislation (Directive 86/609/EEC). The Animal Welfare Committee of the Université de
Namur (UNamur, Belgium) reviewed and approved the complete protocol for Brucella meli-
tensis and B. abortus infection (Permit Number: UN-LE-18/309).
Mice, bacterial strains and reagents
Wild-type (wt) C57BL/6 mice were acquired from Harlan (Bicester, UK). Acod1-/- C57BL/6
mice (49) were acquired from Dr. Eik Hoffmann (University of Lille, France). All wt and defi-
cient mice used in this study were bred in the animal facility of the Gosselies campus of the
Université Libre de Bruxelles (ULB, Belgium).
The wt B. melitensis 16M strain used here was a B. melitensis 16M stably expressing a rap-
idly maturing variant of the red fluorescent protein DsRed (55), the mCherry protein, under
the control of the strong Brucella spp. promoter, psojA. The construction of the mCherry-pro-
ducing Brucella strain has been described previously in detail [37]. We also used mCherry-wt
B. abortus 2308 [41] and mCherry-ΔaceA (isocitrate lyase) B. abortus [40] and the Brucella
abortus 2308 ΔaceA strain complemented with the pMR10OaceA plasmid. Briefly, the aceA
gene and its promoter were amplified with the Q5 High-Fidelity DNA polymerase (New
England Biolabs) with the forward and reverse primers 5’-CGC GGATCC ATT TCC ACC
AGT TCC TGA TC -3’ and 5’-AAAA CTGCAG GGA TTG TTC TTC TGC TCT TTC-3’. The
PCR products were purified (Macherey-Nagel Clean-up kit) and cloned into the EcoRV site of
the pGemT in E. coli DH10B. The aceA gene was then subcloned into the pMR10 plasmid (a
kind gift from C.D. Mohr and R.C. Roberts, Stanford University) with the restriction enzymes
BamHI and PstI. The resulting plasmid was introduced into E. coli strain S17.1 [42] and into B.
abortus 2308 ΔaceA by mating. Brucella strains were always handled under Biosafety Level 3
containment according to Council Directive 98/81/EC of 26 October 1998 and a law of the
Walloon government of 4 July 2002.
Itaconate (Sigma-Aldrich) and dimethyl itaconate (DMI) (Sigma-Aldrich) were diluted in
bidistilled water, while 4-octyl itaconate (4OI) (Sigma-Aldrich) was diluted in DMSO. After
filtration, the solutions were stored at 4˚C.
Murine Bone-Marrow Macrophages culture and infection
Murine Bone-Marrow Macrophages (BMDM) were obtained by sampling tibias and femur
bones from 7- to 12-week-old wild type and Acod1-/- C57BL/6 mice. BMDM were obtained by
seeding 107 bone marrow cells in 75 cm2 flasks in RPMI 1640 Glutamax medium (Gibco) sup-
plemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco) and 10% L929 cell
supernatant containing Macrophage Colony-Stimulating Factor (M-CSF). After 4 days incu-
bation, the medium was changed and cells were put back in the incubator for 3 more days. The
day before the infection, BMDM were seeded in 24-well plates at a concentration of 3.25x105
cells per mL and left in the incubator overnight.
Infections were performed at a multiplicity of infection of 50:1 by centrifuging bacteria
onto BMDM at 170 g for 10 min at 4˚C, and then incubating the cells for 60 min at 37˚C
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under 5% CO2 atmosphere. BMDM were extensively washed with PBS to remove extracellular
bacteria and incubated for an additional 60 min in medium supplemented with either 50 μg/
mL gentamicin to kill extracellular bacteria. One hour later, the medium was replaced by fresh
medium supplemented with 10 μg/mL of gentamicin. At different times post infection,
BMDM were scratched and lysed in PBS/0.1% X-100 Triton (Sigma-Aldrich) and CFU were
plated onto 2YT agar plates using different dilutions to enumerate CFUs.
Brucella infection in vivo
Brucella cultures were grown overnight with shaking at 37˚C in 2YT liquid medium (Luria-
Bertani broth with double quantity of yeast extract) and were washed twice in RPMI 1640
(Gibco Laboratories) (2000 xg, 10 min) before inoculation of the mice.
For intranasal infection, mice were anesthetized with a cocktail of Xylasine (9 mg/kg) and
Ketamine (36 mg/kg) in PBS before being inoculated by intranasal injection with the indicated
dose of Brucella in 30 μl of RPMI. Control animals were inoculated with the same volume of
RPMI. The infectious doses were validated by plating serial dilutions of the inoculums. At the
selected time after infection, mice were sacrificed by cervical dislocation. Immediately after
sacrifice, the lungs and spleen were collected for bacterial count, flow cytometry, qRT-PCR,
purification of the AMs and/or microscopic analyses.
For intraperitoneal infection, mice were injected with 500 μl intraperitoneally of the indi-
cated dose of CFU without anesthesia.
Bacterial counting
Organs were homogenized in PBS/0.1% X-100 Triton (Sigma-Aldrich). We performed succes-
sive serial dilutions in PBS to obtain the most accurate bacterial count and plated them on 2YT
medium. The CFU were counted after 4 days of incubation at 37˚C.
RNA extraction
RNA from the whole lungs and spleen was extract by the Tripure/Chloroform method. Briefly,
the lungs and spleen were harvested from mice, cut into small pieces and homogenized in 1
mL of Tripure (Tripure Isolation Reagent–Roche). After 5 min of incubation at RT, 200 μL of
chloroform was added, and the tube was mixed vigorously for 15 seconds then incubated for
10 min at RT. After centrifugation for 15 min (12,000 xg at 4˚C), the aqueous phase was col-
lected and placed in a new tube. 500 μL of isopropanol was added. The tube was mixed by
inversion and centrifuged for 10 min (12,000 xg at 4˚C). The pellet was washed twice with 75%
ethanol (7,500 xg for 5 min at 4˚C), suspended in 50 μL of water, and incubated for 10 min at
55˚C to completely resuspend the RNA pellet. RNA from purified AMs was extracted using
the RNeasy Mini kit (Qiagen).
RNA sequencing and analysis
After DNAse I, RNAse-free treatment (Thermo Scientific), the RNA samples were then trans-
formed into cDNA, and the library was prepared. The Novaseq 6000 Trueseq SBS reagents (25
million paired-end reads) and Trueseq stranded RNA library preparation were used for the
Illumina sequencing.
Genes with no raw read count were filtered out with an R script. Raw read counts were nor-
malized and a differential expression analysis was performed with DESeq2 by applying an
adjusted p-value < 0.05 and absolute log2-ratio > 0.5849.
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qRT-PCR analysis
RNA was treated with the DNAse I, RNAse-free kit (Thermo Scientific). Briefly, 2 μg of RNA
was treated for 30 min with DNAse I at 37˚C followed by DNAse I inactivation with 50 mM of
EDTA for 10 min at 65˚C. The RNA was then reverse transcribed with Superscript II reverse
transcriptase (Invitrogen) with hexamer random primers as described by the manufacturer. A
condition without reverse transcriptase was also conducted in parallel as a negative control.
cDNA was then mixed with SybrGreen mix (FastStart universal SYBR Green Master (Rox);
Roche) and the appropriate primer sets and subjected to qRT-PCR in a LightCycler 96
(Roche). The forward and reverse primers used were 5’-GGC ACA GAA GTG TTC CAT
AAA GT-3’ and 5’-GAG GCA GGG CTT CCG ATA G-3’ for Acod1, 5’-GCG AAC AAA GCC
AGA TGC AA-3’ and 5’-CCC CTT TCC TCC CAA ACC AA-3’ for Tnf, 5’-CGC ATG TTC
CTG GGG AGA TT-3’ and 5’-TGG GAT GCA ACA TGG CTC TT-3’ for IL-1, 5’-GGC TTG
CCC CAC TAC TTA GG-3’ and 5’-GCG AAC AAA GCC AGA TGC AA-3’ for IL-6. TATA
binding protein (Tbp, forward 5’-GTT GGG GTG GCA TTT TCT GTG-3’, reverse 5’-GGC
CTC TGC ATG TGT TCT CAT-3’) mRNA was used as the reference housekeeping gene for
normalization. A total of 45 three-step cycles were performed as follows: 95˚C for 10 sec, 60˚C
for 10 sec, and 92˚C for 10 sec. Melting curves were then performed to assess primer specific-
ity. The target mRNA fold change was calculated based on the 2-ΔΔCt formula, where the Tbp
gene was used as the reference gene, and RNA from naïve mice was used as the standard con-
dition. At least 6 biological replicates and 3 technical replicates were performed for each gene
tested.
Bioscreen analysis
Overnight cultures were prepared in 2YT rich medium the day before in order to obtain an
OD600 nm between 0.2–0.5 the day after. Cultures were washed twice in PBS (2000 xg for 10
min at RT), and then suspended in 2 YT rich medium or Plommet-Erythritol minimal
medium [30] to obtain an OD600 nm = 0.05 in a final volume of 700 μL. We used the Bioscreen
system (Thermo Fisher) to measure the growth of Brucella at 37˚C for 72 hours.
Brucella melitensis staining with eFluor670
For some histological and flow cytometry experiments, we stained B. melitensis with eFluor670
labelling. Cultures (10 mL) were grown overnight as indicated above, bacteria from 1 mL of
culture were centrifuged (2 min, 7500 xg, RT) and the pellets were washed 3 times with 1 mL
of PBS. Then, the bacteria were incubated for 20 min at RT in the dark with eFluor670 dye at
the final concentration of 10 μM in 1 mL of PBS. After incubation, the bacteria were washed
three times in 1 mL of PBS and diluted once in PBS to obtain the precise infectious dose before
inoculation of the mice.
Cytofluorometric analysis
The lungs were harvested and cut into small pieces and incubated for 1 hour at 37˚C with a
mix of 100 μg/mL of DNAse I fraction IX (Sigma-Aldrich) and 1.6 mg/mL of collagenase (400
Mandl U/mL), as described previously (6). The cells were then washed, filtered and incubated
with saturating doses of purified 2.4G2 (anti-mouse Fc receptor, ATCC) in 200 μl PBS, 0.2%
BSA, 0.02% NaN3 (FACS buffer) for 20 min at 4˚C to prevent antibody (Ab) binding to the Fc
receptor. 3–5x106 cells were stained on ice with various fluorescent mAb combinations in
FACS buffer: BV650-coupled RA3-6B2 (anti-B220, BD Horizon), FITC-coupled RA3-6B2
(anti-B220, BD Pharmingen), Alexa Fluor 700-coupled M1/70 (anti-CD11b, BD Pharmingen),
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BV421-coupled N418 (anti-CD11c, BD Horizon), BV480-coupled P84 (anti-CD172a, BD
OptiBuild), BV711-coupled 1D3 (anti-CD19, BD Horizon), FITC-coupled 1D3 (anti-CD19,
BD Pharmingen), BV786-coupled H194-112 (anti-CD26, BD OptiBuild), FITC-coupled 145-
2C11 (anti-CD3e, BD Pharmingen), Pacific Blue-coupled 500A2 (anti-CD3e, BD Horizon),
Alexa Fluor 700-coupled RM4-5 (anti-CD4, BD Pharmingen), PE-CF594-coupled 30-F11
(anti-CD45, BD Horizon), APC-coupled 53–7.3 (anti-CD5, BD Pharmingen), BV650-coupled
X45-5/7.1 (anti-CD64, BD OptiBuild), APC-H7-coupled 53–6.7 (anti-CD8α, BD Pharmin-
gen), FITC-coupled BM8 (anti-F4/80, eBiosciences), BV711-coupled M5/114.15.2 (anti-I-A/
I-E, BD Horizon), PerCP-Cy5.5-coupled HK1.4 (anti-Ly6C, BioLegend), APC-H7-coupled
1A8 (anti-Ly6G, BD Pharmingen), FITC-coupled PK136 (anti-NK1.1, BD Pharmingen), PE-
coupled PK136 (anti-NK1.1, BD Pharmingen), PE-coupled E50-2440 (anti-Siglec F, BD Phar-
mingen), FITC-coupled GL3 (anti-TCR γδ, BD Pharmingen), APC-coupled ZET (anti-XCR1,
BioLegend). The cells were analyzed on a CytoFLEX LX (Beckman Coulter, 6 lasers) flow
cytometer.
Immunofluorescence microscopy of the lungs
Lungs were fixed for 20 minutes at RT in 2% paraformaldehyde (PFA). Then, still in 2% PFA,
they were placed under a vacuum until no air was present in the lungs for 2 hours. The purpose
of fixation is to kill Brucella so that the tissues can then be manipulated outside the biosafety
level 3 laboratory. After PFA fixation and two washes in PBS, the lungs were incubated over-
night at 4˚C in a 20% PBS-sucrose solution. The tissues were then embedded in Tissue-Tek
OCT compound (Sakura), frozen in liquid nitrogen, and cryostat sections (5 μm) were pre-
pared. For staining, the tissue sections were rehydrated in PBS and incubated in a PBS solution
containing 1% blocking reagent (Boeringer) (PBS-BR 1%) for 20 min before incubation over-
night in PBS-BR 1% containing the following: the DAPI nucleic acid stain Alexa Fluor 350,
488 phalloidin (Molecular Probes) and Alexa Fluor 647–coupled RB6-8C5 anti-Ly6G/Ly6C
(Gr1) (Biolegend). Slides were mounted in Fluoro-Gel medium (Electron Microscopy Sci-
ences, Hatfield, PA). Labelled tissue sections were visualized with an Axiovert M200 inverted
microscope (Zeiss, Iena, Germany) equipped with a high-resolution monochrome camera
(AxioCam HR, Zeiss). Images (1384x1036 pixels, 0.16 μm/pixel) were acquired sequentially
for each fluorochrome with A-Plan 10x/0.25 N.A. and LD-Plan-NeoFluar 63x/0.75 N.A. dry
objectives and recorded as eight-bit grey-level �.zvi files. At least 3 slides were analyzed per
organ from 3 different animals and the results are representative of 2 independent
experiments.
Purification and transmission electron microcopy analysis of alveolar
macrophages
Pulmonary alveolar macrophages were obtained by homogenization and filtration of lungs,
density gradient centrifugation (5 mL of 1.085 g/cm3 nycodenz were mixed with the cells, then
5 mL of cold RPMI was added gently above the nycodenz, and the tube was centrifuged at
1700 x g for 30 min, with minimum braking). CD11c-specific Magnetic associated cell sorting
(MACS) was performed on the low-density cells collected at the interface between the nyco-
denz and RPMI using MiniMACS, MS column and CD11c+ magnetic beads (Miltenyl Biotec).
Purified alveolar macrophages were fixed for 2 hours in 2.5% glutaraldehyde in 0.1 M caco-
dylate buffer at 4˚C, washed 3 times (4000 xg, 5 min) with 0.2 M cacodylate buffer then post-
fixed in 2% osmium tetroxide in 0.1 M cacodylate buffer for 1 hour at RT. After 3 washes,
samples were serially dehydrated in ethanol (30% EtOH first for 5 min, followed by 10 min–
the same for 50%, 70%, 85%, 100% EtOH). Propylene oxide was then added 4x5 min at RT
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and the pellet was progressively embedded in epoxy resin (Agar 100 resin; Agar Scientific,
United Kingdom) (75:25, 50:50 and then 25:75% of propylene oxide/resin). Ultrathin 50-nm
sections were obtained, mounted on copper-Formvar-carbon grids (EMS, United Kingdom),
and stained with uranyl acetate and lead citrate by standard procedures. Observations were
made on a Tecnai 10 electron microscope (FEI, Eindhoven, The Netherlands), and images
were captured with a Veleta charge-coupled-device (CCD) camera and processed using the
AnalySIS and Adobe Photoshop software programs.
Structural analysis
The docking of itaconate into the catalytic site of isocitrate lyase from Brucella abortus was per-
formed using Maestro 11.9 from Schrodinger’s suite 2019. The starting crystal structure corre-
sponds to a complex of the enzyme with malonate (chain A of 3OQ8 PDB entry). The
itaconate ligand (doubly deprotonate dicarboxylate form) was build based on the malonate
from this PDB structure (using “3D Builder” tool). The resulting complex was further mini-
mized using the “Protein Preparation Wizard” [43]. Interactions were analyzed with Maestro
11.9 and visualized with the software Pymol (version 1.7.4.4; Schrödinger).
A crystal structure of Brucella abortus isocitrate lyase in complex with itaconate has also
been obtained at 1.8 Å resolution. Statistics of data collection and refinement together with
coordinates have been deposited at the PDB (entry 7RBX).
Statistical analysis
We used a (Wilcoxon-)Mann-Whitney test provided by the GraphPad Prism software to statis-
tically analyze our results. Each group of deficient mice was compared to the wt mice. We also
compared each group with the other groups and displayed the results when required. Values
of p< 0.05 were considered to represent a significant difference. �, ��, ��� denote p< 0.05,
p< 0.01, p< 0.001 respectively.
Supporting information
S1 Fig. Alveolar macrophages are the main B. melitensis infected cells in lungs. Wild-type
C57BL/6 mice (n = 5) received PBS intranasally (control mice) or 107 CFU of mCherry-
expressing B. melitensis labelled with eFluor670. Mice were sacrificed at 24 hours post-infec-
tion. The lungs were harvested, and the cells were isolated and then analyzed by flow cytome-
try for the FSC and the expression of eFluor670, mCherry, CD11c, and Siglec-F as indicated.
(A) Gating strategy. Numbers indicate the percentage of eFluor670+ cells among the total cells
(upper panels) and the percentage of eFluor670+ cells that are also positive for CD11c and
Siglec-F markers (lower panels) in naïve mice (left-hand panels) or infected mice (right-hand
panels). B. Same gating strategies, but with previously purified alveolar macrophages. These
results are representative of three independent experiments.
(TIF)
S2 Fig. Acod1 gene deficiency does not affect does not affect splenomegaly induced following
Brucella infection. Wild-type and Acod1-/- C57BL/6 mice were intranasally infected with 107
CFU of wild-type B. melitensis 16M or B. abortus 2308, as indicated. At 2-, 5-, 9- and 28-days
post-infection, spleen were harvested and weighed individually. Each point represents one
mouse, n = 8. Grey bar represents the mean. ns = non-significant differences between the indi-
cated groups. Data are representative of 2 independent experiments.
(TIF)
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S3 Fig. Acod1 gene deficiency does not affect B. abortus control in the spleen from intra-
peritoneally infected mice. Wild-type and Acod1-/- C57BL/6 mice were intraperitoneally
infected with 107 CFU of wild-type B. abortus 2308, as indicated. At 2-, 5- and 9-days post-
infection, spleen were harvested and CFU were counted. Each point represents one mouse,
n = 8. Grey bar represents the mean. ns = non-significant differences between the indicated
groups. Data are representative of 2 independent experiments.
(TIF)
S4 Fig. Gating strategy of flow cytometry analysis. Representative picture of the gating strat-
egies used for the discrimination of alveolar macrophages (AM), classical dendritic cells,
monocytes, neutrophils, eosinophils, B cells, CD4+T cells, CD8+T cells, γδT cells, NK T cells
and NK cells among lung cells from naive wild type C57BL/6 mice analyzed using CytoFLEX
flow cytometer (Beckman Coulter, 6 lasers). “Lineage” staining groups together the markers
CD3, CD19, B220 and NK1.1. The numbers indicate the percentages in each quadrant.
(TIF)
S5 Fig. 4-octyl itaconate inhibits Brucella growth in vitro. Comparison of the impact of dif-
ferent concentrations of 4-octyl itaconate on the growth of wild-type B. melitensis or B. abortus
in rich medium (2YT). The bacteria were grown for 72 hours at 37˚C and the OD was mea-
sured every 30 min in a Bioscreen system. The standard deviation was obtained from three
independent experiments.
(TIF)
S6 Fig. Dimethyl itaconate is bactericidal for B. abortus. A pre-culture of B. abortus was pre-
pared in 2YT and was then washed and diluted 10 times in Plommet Erythritol medium sup-
plemented (10 mM DMI) or not (ctl) with 10 mM of DMI. The cultures have grown at 37˚C
overnight. The day after, cultures were washed twice in PBS and plated on 2YT using serial
dilutions to obtain a countable number of CFU. Experiment was repeated 2 times, in tripli-
cates. Significant difference between the two groups is marked with asterisks: ���p < 0.001.
(TIF)
S7 Fig. Dimethyl itaconate impacts wild-type and ΔaceA B. abortus morphology in vitro.
Transmission electronic microscopy images were performed as described in the Materials and
Methods section on wild-type and ΔaceA B. abortus, cultured in poor medium (Plommet-Ery-
thritol) overnight supplemented or not with 1 mM of dimethyl itaconate. Red arrows indicate
membrane alterations.
(TIF)
S1 Data. RNAseq of whole lungs from infected versus naïve mice. Wild-type C57BL/6 mice
intranasally infected with 107 CFU of wild-type B. melitensis (n = 3), or receiving the same vol-
ume of PBS (naïve group) (n = 3), were sacrificed at 24 hours post-infection. Lungs were har-
vested and RNA was extracted. RNAseq was performed with the Illumina system and Deseq2
analysis as described in the Materials and Methods. Data represent the list of genes associated
with their fold change (FC) (Log2) and adjusted p-value—log10 (false discovery rate, FDR).
Data are representative of two independent experiments. These data have been deposited in
the GEO database under the reference GSE180699.
(XLSX)
S2 Data. RNAseq of alveolar macrophages from infected versus naïve mice. Wild-type
C57BL/6 mice intranasally infected with 107 CFU of wild-type B. melitensis (n = 3), or receiv-
ing the same volume of PBS (naïve group) (n = 3), were sacrificed at 24 hours post-infection.
Lungs were harvested, alveolar macrophages were purified and RNA was extracted. RNAseq
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was performed with the Illumina system and Deseq2 analysis as described in the Materials and
Methods. Data represent the list of genes associated with their fold change (FC) (Log2) and
adjusted p-value—log10 (false discovery rate, FDR). Data are representative of two indepen-
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